Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis

Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). We pooled data from 5 cohorts of patients treated with bedaquiline in France, Georgia, Armenia, and South Africa and in a multicountry st...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Emerg Infect Dis
Egile Nagusiak: Mbuagbaw, Lawrence, Guglielmetti, Lorenzo, Hewison, Catherine, Bakare, Nyasha, Bastard, Mathieu, Caumes, Eric, Fréchet-Jachym, Mathilde, Robert, Jérôme, Veziris, Nicolas, Khachatryan, Naira, Kotrikadze, Tinatin, Hayrapetyan, Armen, Avaliani, Zaza, Schünemann, Holger J., Lienhardt, Christian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Centers for Disease Control and Prevention 2019
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478224/
https://ncbi.nlm.nih.gov/pubmed/31002070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2505.181823
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak